{"id":11131,"date":"2022-10-29T09:31:43","date_gmt":"2022-10-29T08:31:43","guid":{"rendered":"https:\/\/www.x4lifesciences.com\/?p=11131"},"modified":"2023-02-24T11:44:25","modified_gmt":"2023-02-24T11:44:25","slug":"visionary-world-medtech-gandolf-finke","status":"publish","type":"post","link":"https:\/\/www.x4lifesciences.com\/de\/2022\/10\/29\/visionary-world-medtech-gandolf-finke\/","title":{"rendered":"The Future of Cancer Treatment: Interview with Mika"},"content":{"rendered":"

[vc_row full_width=“stretch_row“ el_class=“dark“][vc_column][vc_column_text]Listed as one of Europe’s top 200 Health Tech’s driving innovation in <\/span>digital health, hear from Mika’s Founder and MD, Gandolf Finke on the future of cancer treatment. <\/span><\/p>\n

We discuss the most exciting developments in the Berlin MedTech industry, how to attract world-class talent and how they are shaping their legacy within healthcare. <\/span><\/p>\n

For more, SUBSCRIBE to the X4 Talks YouTube channel here: <\/span>www.youtube.com\/@X4Talks\/<\/a>[\/vc_column_text][vc_empty_space][vc_custom_heading text=“\ud83d\udca1 The Future of Cancer Treatment“ font_container=“tag:h2|font_size:18|text_align:left|color:%23000000″ use_theme_fonts=“yes“][\/vc_column][\/vc_row][vc_row][vc_column][vc_video link=“https:\/\/youtu.be\/djHJAB82_lE“][\/vc_column][\/vc_row][vc_row][vc_column][\/vc_column][\/vc_row]<\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"

[vc_row full_width=“stretch_row“ el_class=“dark“][vc_column][vc_column_text]Listed as one of Europe’s top 200 Health Tech’s driving innovation in digital health, hear from Mika’s Founder and MD, Gandolf Finke on…<\/p>\n","protected":false},"author":5,"featured_media":11174,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[239,320],"tags":[846],"class_list":["post-11131","post","type-post","status-publish","format-standard","hentry","category-insights","category-thought-leadership","tag-spotlight"],"yoast_head":"\nThe Future of Cancer Treatment: Interview with Mika - X4 Life Sciences<\/title>\n<meta name=\"description\" content=\"In the competitive Berlin MedTech market, standing out from the crowd is key. Founder and MD of Mika, Gandolf Finke, explains how they are working to improve the quality of life for cancer patients through inventive digital therapeutics.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.x4lifesciences.com\/2022\/10\/29\/visionary-world-medtech-gandolf-finke\/\" \/>\n<meta property=\"og:locale\" content=\"de_DE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"The Future of Cancer Treatment: Interview with Mika\" \/>\n<meta property=\"og:description\" content=\"In the competitive Berlin MedTech market, standing out from the crowd is key. Founder and MD of Mika, Gandolf Finke, explains how they are working to improve the quality of life for cancer patients through inventive digital therapeutics.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.x4lifesciences.com\/2022\/10\/29\/visionary-world-medtech-gandolf-finke\/\" \/>\n<meta property=\"og:site_name\" content=\"X4 Life Sciences\" \/>\n<meta property=\"article:published_time\" content=\"2022-10-29T08:31:43+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-02-24T11:44:25+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.x4lifesciences.com\/wp-content\/uploads\/sites\/21\/2022\/10\/X4-TALKS-THUMBNAILS-2.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1280\" \/>\n\t<meta property=\"og:image:height\" content=\"720\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"dchurch\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"dchurch\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 Minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.x4lifesciences.com\\\/2022\\\/10\\\/29\\\/visionary-world-medtech-gandolf-finke\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.x4lifesciences.com\\\/2022\\\/10\\\/29\\\/visionary-world-medtech-gandolf-finke\\\/\"},\"author\":{\"name\":\"dchurch\",\"@id\":\"https:\\\/\\\/www.x4lifesciences.com\\\/#\\\/schema\\\/person\\\/37c7cd74386b30bccf2a6c70b6e397e3\"},\"headline\":\"The Future of Cancer Treatment: Interview with Mika\",\"datePublished\":\"2022-10-29T08:31:43+00:00\",\"dateModified\":\"2023-02-24T11:44:25+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.x4lifesciences.com\\\/2022\\\/10\\\/29\\\/visionary-world-medtech-gandolf-finke\\\/\"},\"wordCount\":149,\"commentCount\":0,\"image\":{\"@id\":\"https:\\\/\\\/www.x4lifesciences.com\\\/2022\\\/10\\\/29\\\/visionary-world-medtech-gandolf-finke\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.x4lifesciences.com\\\/wp-content\\\/uploads\\\/sites\\\/21\\\/2022\\\/10\\\/X4-TALKS-THUMBNAILS-2.jpg\",\"keywords\":[\"Spotlight\"],\"articleSection\":[\"Insights\",\"Thought Leadership\"],\"inLanguage\":\"de-DE\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/www.x4lifesciences.com\\\/2022\\\/10\\\/29\\\/visionary-world-medtech-gandolf-finke\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.x4lifesciences.com\\\/2022\\\/10\\\/29\\\/visionary-world-medtech-gandolf-finke\\\/\",\"url\":\"https:\\\/\\\/www.x4lifesciences.com\\\/2022\\\/10\\\/29\\\/visionary-world-medtech-gandolf-finke\\\/\",\"name\":\"The Future of Cancer Treatment: Interview with Mika - X4 Life Sciences\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.x4lifesciences.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.x4lifesciences.com\\\/2022\\\/10\\\/29\\\/visionary-world-medtech-gandolf-finke\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.x4lifesciences.com\\\/2022\\\/10\\\/29\\\/visionary-world-medtech-gandolf-finke\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.x4lifesciences.com\\\/wp-content\\\/uploads\\\/sites\\\/21\\\/2022\\\/10\\\/X4-TALKS-THUMBNAILS-2.jpg\",\"datePublished\":\"2022-10-29T08:31:43+00:00\",\"dateModified\":\"2023-02-24T11:44:25+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.x4lifesciences.com\\\/#\\\/schema\\\/person\\\/37c7cd74386b30bccf2a6c70b6e397e3\"},\"description\":\"In the competitive Berlin MedTech market, standing out from the crowd is key. Founder and MD of Mika, Gandolf Finke, explains how they are working to improve the quality of life for cancer patients through inventive digital therapeutics.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.x4lifesciences.com\\\/2022\\\/10\\\/29\\\/visionary-world-medtech-gandolf-finke\\\/#breadcrumb\"},\"inLanguage\":\"de-DE\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.x4lifesciences.com\\\/2022\\\/10\\\/29\\\/visionary-world-medtech-gandolf-finke\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"de-DE\",\"@id\":\"https:\\\/\\\/www.x4lifesciences.com\\\/2022\\\/10\\\/29\\\/visionary-world-medtech-gandolf-finke\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.x4lifesciences.com\\\/wp-content\\\/uploads\\\/sites\\\/21\\\/2022\\\/10\\\/X4-TALKS-THUMBNAILS-2.jpg\",\"contentUrl\":\"https:\\\/\\\/www.x4lifesciences.com\\\/wp-content\\\/uploads\\\/sites\\\/21\\\/2022\\\/10\\\/X4-TALKS-THUMBNAILS-2.jpg\",\"width\":1280,\"height\":720},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.x4lifesciences.com\\\/2022\\\/10\\\/29\\\/visionary-world-medtech-gandolf-finke\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.x4lifesciences.com\\\/de\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"The Future of Cancer Treatment: Interview with Mika\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.x4lifesciences.com\\\/#website\",\"url\":\"https:\\\/\\\/www.x4lifesciences.com\\\/\",\"name\":\"X4 Life Sciences\",\"description\":\"Life Sciences Recruitment Specialists\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.x4lifesciences.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"de-DE\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.x4lifesciences.com\\\/#\\\/schema\\\/person\\\/37c7cd74386b30bccf2a6c70b6e397e3\",\"name\":\"dchurch\",\"url\":\"https:\\\/\\\/www.x4lifesciences.com\\\/de\\\/author\\\/dchurch\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"The Future of Cancer Treatment: Interview with Mika - X4 Life Sciences","description":"In the competitive Berlin MedTech market, standing out from the crowd is key. Founder and MD of Mika, Gandolf Finke, explains how they are working to improve the quality of life for cancer patients through inventive digital therapeutics.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.x4lifesciences.com\/2022\/10\/29\/visionary-world-medtech-gandolf-finke\/","og_locale":"de_DE","og_type":"article","og_title":"The Future of Cancer Treatment: Interview with Mika","og_description":"In the competitive Berlin MedTech market, standing out from the crowd is key. Founder and MD of Mika, Gandolf Finke, explains how they are working to improve the quality of life for cancer patients through inventive digital therapeutics.","og_url":"https:\/\/www.x4lifesciences.com\/2022\/10\/29\/visionary-world-medtech-gandolf-finke\/","og_site_name":"X4 Life Sciences","article_published_time":"2022-10-29T08:31:43+00:00","article_modified_time":"2023-02-24T11:44:25+00:00","og_image":[{"width":1280,"height":720,"url":"https:\/\/www.x4lifesciences.com\/wp-content\/uploads\/sites\/21\/2022\/10\/X4-TALKS-THUMBNAILS-2.jpg","type":"image\/jpeg"}],"author":"dchurch","twitter_card":"summary_large_image","twitter_misc":{"Written by":"dchurch","Est. reading time":"1 Minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.x4lifesciences.com\/2022\/10\/29\/visionary-world-medtech-gandolf-finke\/#article","isPartOf":{"@id":"https:\/\/www.x4lifesciences.com\/2022\/10\/29\/visionary-world-medtech-gandolf-finke\/"},"author":{"name":"dchurch","@id":"https:\/\/www.x4lifesciences.com\/#\/schema\/person\/37c7cd74386b30bccf2a6c70b6e397e3"},"headline":"The Future of Cancer Treatment: Interview with Mika","datePublished":"2022-10-29T08:31:43+00:00","dateModified":"2023-02-24T11:44:25+00:00","mainEntityOfPage":{"@id":"https:\/\/www.x4lifesciences.com\/2022\/10\/29\/visionary-world-medtech-gandolf-finke\/"},"wordCount":149,"commentCount":0,"image":{"@id":"https:\/\/www.x4lifesciences.com\/2022\/10\/29\/visionary-world-medtech-gandolf-finke\/#primaryimage"},"thumbnailUrl":"https:\/\/www.x4lifesciences.com\/wp-content\/uploads\/sites\/21\/2022\/10\/X4-TALKS-THUMBNAILS-2.jpg","keywords":["Spotlight"],"articleSection":["Insights","Thought Leadership"],"inLanguage":"de-DE","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.x4lifesciences.com\/2022\/10\/29\/visionary-world-medtech-gandolf-finke\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.x4lifesciences.com\/2022\/10\/29\/visionary-world-medtech-gandolf-finke\/","url":"https:\/\/www.x4lifesciences.com\/2022\/10\/29\/visionary-world-medtech-gandolf-finke\/","name":"The Future of Cancer Treatment: Interview with Mika - X4 Life Sciences","isPartOf":{"@id":"https:\/\/www.x4lifesciences.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.x4lifesciences.com\/2022\/10\/29\/visionary-world-medtech-gandolf-finke\/#primaryimage"},"image":{"@id":"https:\/\/www.x4lifesciences.com\/2022\/10\/29\/visionary-world-medtech-gandolf-finke\/#primaryimage"},"thumbnailUrl":"https:\/\/www.x4lifesciences.com\/wp-content\/uploads\/sites\/21\/2022\/10\/X4-TALKS-THUMBNAILS-2.jpg","datePublished":"2022-10-29T08:31:43+00:00","dateModified":"2023-02-24T11:44:25+00:00","author":{"@id":"https:\/\/www.x4lifesciences.com\/#\/schema\/person\/37c7cd74386b30bccf2a6c70b6e397e3"},"description":"In the competitive Berlin MedTech market, standing out from the crowd is key. Founder and MD of Mika, Gandolf Finke, explains how they are working to improve the quality of life for cancer patients through inventive digital therapeutics.","breadcrumb":{"@id":"https:\/\/www.x4lifesciences.com\/2022\/10\/29\/visionary-world-medtech-gandolf-finke\/#breadcrumb"},"inLanguage":"de-DE","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.x4lifesciences.com\/2022\/10\/29\/visionary-world-medtech-gandolf-finke\/"]}]},{"@type":"ImageObject","inLanguage":"de-DE","@id":"https:\/\/www.x4lifesciences.com\/2022\/10\/29\/visionary-world-medtech-gandolf-finke\/#primaryimage","url":"https:\/\/www.x4lifesciences.com\/wp-content\/uploads\/sites\/21\/2022\/10\/X4-TALKS-THUMBNAILS-2.jpg","contentUrl":"https:\/\/www.x4lifesciences.com\/wp-content\/uploads\/sites\/21\/2022\/10\/X4-TALKS-THUMBNAILS-2.jpg","width":1280,"height":720},{"@type":"BreadcrumbList","@id":"https:\/\/www.x4lifesciences.com\/2022\/10\/29\/visionary-world-medtech-gandolf-finke\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.x4lifesciences.com\/de\/"},{"@type":"ListItem","position":2,"name":"The Future of Cancer Treatment: Interview with Mika"}]},{"@type":"WebSite","@id":"https:\/\/www.x4lifesciences.com\/#website","url":"https:\/\/www.x4lifesciences.com\/","name":"X4 Life Sciences","description":"Life Sciences Recruitment Specialists","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.x4lifesciences.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"de-DE"},{"@type":"Person","@id":"https:\/\/www.x4lifesciences.com\/#\/schema\/person\/37c7cd74386b30bccf2a6c70b6e397e3","name":"dchurch","url":"https:\/\/www.x4lifesciences.com\/de\/author\/dchurch\/"}]}},"_links":{"self":[{"href":"https:\/\/www.x4lifesciences.com\/de\/wp-json\/wp\/v2\/posts\/11131","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.x4lifesciences.com\/de\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.x4lifesciences.com\/de\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.x4lifesciences.com\/de\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/www.x4lifesciences.com\/de\/wp-json\/wp\/v2\/comments?post=11131"}],"version-history":[{"count":6,"href":"https:\/\/www.x4lifesciences.com\/de\/wp-json\/wp\/v2\/posts\/11131\/revisions"}],"predecessor-version":[{"id":11136,"href":"https:\/\/www.x4lifesciences.com\/de\/wp-json\/wp\/v2\/posts\/11131\/revisions\/11136"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.x4lifesciences.com\/de\/wp-json\/wp\/v2\/media\/11174"}],"wp:attachment":[{"href":"https:\/\/www.x4lifesciences.com\/de\/wp-json\/wp\/v2\/media?parent=11131"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.x4lifesciences.com\/de\/wp-json\/wp\/v2\/categories?post=11131"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.x4lifesciences.com\/de\/wp-json\/wp\/v2\/tags?post=11131"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}